BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellavia D, Veronesi F, Carina V, Costa V, Raimondi L, De Luca A, Alessandro R, Fini M, Giavaresi G. Gene therapy for chondral and osteochondral regeneration: is the future now? Cell Mol Life Sci 2018;75:649-67. [DOI: 10.1007/s00018-017-2637-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Xu S, Wu X. miR-134 inhibits chondrogenic differentiation of bone marrow mesenchymal stem cells by targetting SMAD6. Biosci Rep 2019;39:BSR20180921. [PMID: 30135141 DOI: 10.1042/BSR20180921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Masaoutis C, Theocharis S. The Role of Exosomes in Bone Remodeling: Implications for Bone Physiology and Disease. Dis Markers 2019;2019:9417914. [PMID: 31485281 DOI: 10.1155/2019/9417914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
3 South S, Lucero J, Vijayagopal P, Juma S. Anti-Inflammatory Action of Blueberry Polyphenols in HIG-82 Rabbit Synoviocytes. Journal of Medicinal Food 2019;22:1032-40. [DOI: 10.1089/jmf.2019.0046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Tanikella AS, Hardy MJ, Frahs SM, Cormier AG, Gibbons KD, Fitzpatrick CK, Oxford JT. Emerging Gene-Editing Modalities for Osteoarthritis. Int J Mol Sci 2020;21:E6046. [PMID: 32842631 DOI: 10.3390/ijms21176046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tschon M, Brogini S, Parrilli A, Bertoldi S, Silini A, Parolini O, Faré S, Martini L, Veronesi F, Fini M, Giavaresi G. Assessment of the in vivo biofunctionality of a biomimetic hybrid scaffold for osteochondral tissue regeneration. Biotechnol Bioeng 2021;118:465-80. [PMID: 32997340 DOI: 10.1002/bit.27584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chen T, Cao F, Wu X, Peng W, Zhi W, Weng J, Zhang X, Wang J. Constructing Gene-Enhanced Tissue Engineering for Regeneration and Repair of Osteochondral Defects. Adv Biosyst 2019;3:e1900004. [PMID: 32648702 DOI: 10.1002/adbi.201900004] [Reference Citation Analysis]
7 Gonçalves AM, Moreira A, Weber A, Williams GR, Costa PF. Osteochondral Tissue Engineering: The Potential of Electrospinning and Additive Manufacturing. Pharmaceutics 2021;13:983. [PMID: 34209671 DOI: 10.3390/pharmaceutics13070983] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu Y, Li M, Yin Z, Zhou S, Qiu Y. SUMO-modified bone marrow mesenchymal stem cells promoted the repair of articular cartilage in rats. Cell Biol Int 2020;44:560-8. [PMID: 31642552 DOI: 10.1002/cbin.11256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bellavia D, Raimondi L, Costa V, De Luca A, Carina V, Maglio M, Fini M, Alessandro R, Giavaresi G. Engineered exosomes: A new promise for the management of musculoskeletal diseases. Biochim Biophys Acta Gen Subj 2018;1862:1893-901. [PMID: 29885361 DOI: 10.1016/j.bbagen.2018.06.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
10 Seca S, Franconi G. Understanding Chinese Medicine Patterns of Rheumatoid Arthritis and Related Biomarkers. Medicines (Basel) 2018;5:E17. [PMID: 29401671 DOI: 10.3390/medicines5010017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Madry H, Gao L, Rey‐rico A, Venkatesan JK, Müller‐brandt K, Cai X, Goebel L, Schmitt G, Speicher‐mentges S, Zurakowski D, Menger MD, Laschke MW, Cucchiarini M. Thermosensitive Hydrogel Based on PEO–PPO–PEO Poloxamers for a Controlled In Situ Release of Recombinant Adeno‐Associated Viral Vectors for Effective Gene Therapy of Cartilage Defects. Adv Mater 2020;32:1906508. [DOI: 10.1002/adma.201906508] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
12 Yao X, Wei W, Wang X, Chenglin L, Björklund M, Ouyang H. Stem cell derived exosomes: microRNA therapy for age-related musculoskeletal disorders. Biomaterials 2019;224:119492. [PMID: 31557588 DOI: 10.1016/j.biomaterials.2019.119492] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
13 Georgiev T. Multimodal approach to intraarticular drug delivery in knee osteoarthritis. Rheumatol Int 2020;40:1763-9. [PMID: 32803403 DOI: 10.1007/s00296-020-04681-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Chen T, Weng W, Liu Y, Aspera-Werz RH, Nüssler AK, Xu J. Update on Novel Non-Operative Treatment for Osteoarthritis: Current Status and Future Trends. Front Pharmacol 2021;12:755230. [PMID: 34603064 DOI: 10.3389/fphar.2021.755230] [Reference Citation Analysis]
15 Xue P, Yuan J, Yao Q, Zhao Y, Xu H. Bioactive Factors-imprinted Scaffold Vehicles for Promoting Bone Healing: The Potential Strategies and the Confronted Challenges for Clinical Production. BIO Integration 2020;1:37-54. [DOI: 10.15212/bioi-2020-0010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Co CM, Izuagbe S, Zhou J, Zhou N, Sun X, Borrelli J, Tang L. Click chemistry-based pre-targeting cell delivery for cartilage regeneration. Regen Biomater 2021;8:rbab018. [PMID: 34211730 DOI: 10.1093/rb/rbab018] [Reference Citation Analysis]
17 Medvedeva EV, Grebenik EA, Gornostaeva SN, Telpuhov VI, Lychagin AV, Timashev PS, Chagin AS. Repair of Damaged Articular Cartilage: Current Approaches and Future Directions. Int J Mol Sci 2018;19:E2366. [PMID: 30103493 DOI: 10.3390/ijms19082366] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 20.3] [Reference Citation Analysis]
18 Kulchar RJ, Denzer BR, Chavre BM, Takegami M, Patterson J. A Review of the Use of Microparticles for Cartilage Tissue Engineering. Int J Mol Sci 2021;22:10292. [PMID: 34638629 DOI: 10.3390/ijms221910292] [Reference Citation Analysis]
19 Alkaya D, Gurcan C, Kilic P, Yilmazer A, Gurman G. Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration? 3 Biotech 2020;10:161. [PMID: 32206495 DOI: 10.1007/s13205-020-2134-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Venkatesan JK, Rey-Rico A, Cucchiarini M. Current Trends in Viral Gene Therapy for Human Orthopaedic Regenerative Medicine. Tissue Eng Regen Med 2019;16:345-55. [PMID: 31413939 DOI: 10.1007/s13770-019-00179-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
21 Watson Levings RS, Broome TA, Smith AD, Rice BL, Gibbs EP, Myara DA, Hyddmark EV, Nasri E, Zarezadeh A, Levings PP, Lu Y, White ME, Dacanay EA, Foremny GB, Evans CH, Morton AJ, Winter M, Dark MJ, Nickerson DM, Colahan PT, Ghivizzani SC. Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model. Hum Gene Ther Clin Dev 2018;29:90-100. [PMID: 29869540 DOI: 10.1089/humc.2017.142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
22 Gabner S, Ertl R, Velde K, Renner M, Jenner F, Egerbacher M, Hlavaty J. Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment. J Gene Med 2018;20:e3021. [PMID: 29608232 DOI: 10.1002/jgm.3021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
23 Saghati S, Nasrabadi HT, Khoshfetrat AB, Moharamzadeh K, Hassani A, Mohammadi SM, Rahbarghazi R, Fathi Karkan S. Tissue Engineering Strategies to Increase Osteochondral Regeneration of Stem Cells; a Close Look at Different Modalities. Stem Cell Rev Rep 2021;17:1294-311. [PMID: 33547591 DOI: 10.1007/s12015-021-10130-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Uzieliene I, Kalvaityte U, Bernotiene E, Mobasheri A. Non-viral Gene Therapy for Osteoarthritis. Front Bioeng Biotechnol 2020;8:618399. [PMID: 33520968 DOI: 10.3389/fbioe.2020.618399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Weissenberger M, Weissenberger MH, Gilbert F, Groll J, Evans CH, Steinert AF. Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery. BMC Musculoskelet Disord 2020;21:109. [PMID: 32066427 DOI: 10.1186/s12891-020-3137-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
26 Vaiserman A, De Falco E, Koliada A, Maslova O, Balistreri CR. Anti-ageing gene therapy: Not so far away? Ageing Res Rev 2019;56:100977. [PMID: 31669577 DOI: 10.1016/j.arr.2019.100977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]